User menu

Rodent rhabdomyosarcoma : comparison between total choline concentration at H-MRS and [18F]-fluoromethylcholine uptake at PET using accurate methods for collecting data.

Bibliographic reference Rommel, Denis ; Bol, Anne ; Abarca-Quinones, Jorge ; Peeters, Frank ; Robert, Annie ; et. al. Rodent rhabdomyosarcoma : comparison between total choline concentration at H-MRS and [18F]-fluoromethylcholine uptake at PET using accurate methods for collecting data.. In: Molecular Imaging and Biology, Vol. 12, no. 4, p. 415-423 (2010)
Permanent URL
  1. Wyss MT, Weber B, Honer M et al (2004) 18F-choline in experimental soft tissue infection assessed with autoradiography and high-resolution PET. Eur J Nucl Med Mol Imaging 31:312–316
  2. Kwee SA, DeGrado TR, Talbot JN, Gutman F, Coel MN (2007) Cancer imaging with fluorine-18-labeled choline derivatives. Semin Nucl Med 37:420–428
  3. Katz-Brull R, Degani H (1996) Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method. Anticancer Res 16:1375–1380
  4. Morse DL, Carroll D, Day S et al (2009) Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway. NMR Biomed 22:114–127
  5. Gillies RJ, Morse DL (2005) In vivo magnetic resonance spectroscopy in cancer. Annu Rev Biomed Eng 7:287–326
  6. Glunde K, Jacobs MA, Bhujwalla ZM (2006) Choline metabolism in cancer: implications for diagnosis and therapy. Expert Rev Mol Diagn 6:821–829
  7. Ramírez de Molina A, Rodríguez-González A, Gutiérrez R et al (2002) Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun 296:580–583
  8. Glunde K, Raman V, Mori N, Bhujwalla ZM (2005) RNA interference-mediated choline kinase suppression in breast cancer cells induces differentiation and reduces proliferation. Cancer Res 65:11034–11043
  9. Brindle K (2008) New approaches for imaging tumour responses to treatment. Nat Rev Cancer 8:94–107
  10. Meisamy S, Bolan PJ, Baker EH et al (2004) Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy—a pilot study at 4T. Radiology 233:424–431
  11. Lichy MP, Bachert P, Henze M, Lichy CM, Debus J, Schlemmer HP (2004) Monitoring individual response to brain-tumour chemotherapy: proton MR spectroscopy in a patient with recurrent glioma after stereotactic radiotherapy. Neuroradiology 46:126–129
  12. Tate AR, Underwood J, Acosta DM et al (2006) Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra. NMR Biomed 19:411–434
  13. Groves AM, Win T, Haim SB, Ell PJ (2007) Non-[18F]FDG PET in clinical oncology. Lancet Oncol 8:822–830
  14. Langsteger W, Heinisch M, Fogelman I (2006) The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast. Semin Nucl Med 36:73–92
  15. Talbot J, Gutman F, Fartoux L et al (2006) PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT. Eur J Nucl Med Mol Imaging 33:1285–1289
  16. Price DT, Coleman RE, Liao RP, Robertson CN, Polascik TJ, DeGrado TR (2002) Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. J Urol 168:273–280
  17. Tian M, Zhang H, Oriuchi N, Higuchi T, Endo K (2004) Comparison of 11C-choline PET and FDG PET for the differential diagnosis of malignant tumors. Eur J Nucl Med Mol Imaging 31:1064–1072
  18. DeGrado TR, Coleman RE, Wang S et al (2001) Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res 61:110–117
  19. Utriainen M, Komu M, Vuorinen V et al (2003) Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS. J Neurooncol 62:329–338
  20. Kwee Sandi A., Coel Marc N., Lim John, Ko Jehoon P., Combined Use of F-18 Fluorocholine Positron Emission Tomography and Magnetic Resonance Spectroscopy for Brain Tumor Evaluation, 10.1111/j.1552-6569.2004.tb00253.x
  21. Testa C, Schiavina R, Lodi R et al (2007) Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT. Radiology 244:797–806
  22. Yamaguchi T, Lee J, Uemura H et al (2005) Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy. Eur J Nucl Med Mol Imaging 32:742–748
  23. Animal Welfare AVMA policy—Use of Animals in Research, Testing, and Education (2007) AVMA Website Available via: . Accessed 24 Mar 2009
  24. MRUI Versions (2006) Available via: Accessed 24 Mar 2009
  25. de Beer R, van den Boogaart A, van Ormondt D et al (1992) Application of time-domain fitting in the quantification of in vivo 1H spectroscopic imaging data sets. NMR Biomed 5:171–178
  26. van den Boogaart A, van Ormondt D, Pijnappel W, de Beer R, Ala-Korpela M (1994) Mathematics in signal processing III. Clarendon Press, Oxford
  27. Iwata R, Pascali C, Bogni A, Furumoto S, Terasaki K, Yanai K (2002) [18F]fluoromethyl triflate, a novel and reactive [18F]fluoromethylating agent : preparation and application to the on-column preparation of [18F]fluorocholine. Appl Radiat Isot 5:347–352
  28. Iwata R, Pascali C, Bogni A, Miyake Y, Yanai K, Ido T (2001) A simple loop method for the automated preparation of [11C]raclopride from [11C]methyl triflate. Appl Radiat Isot 55:17–22
  29. AVMA (2007) AVMA Guidelines on Euthanasia. Available via: . Accessed 24 Mar 2009
  30. Podo F (1999) Tumour phospholipid metabolism. NMR Biomed 12:413–439
  31. Iorio E, Mezzanzanica D, Alberti P et al (2005) Alterations of choline phospholipid metabolism in ovarian tumor progression. Cancer Res 65:9369–9376
  32. Villa A, Caporizzo E, Papagni A et al (2005) Choline and phosphatidylcholine fluorescent derivatives localization in carcinoma cells studied by laser scanning confocal fluorescence microscopy. Eur J Cancer 41:1453–1459
  33. Michel V, Yuan Z, Ramsubir S, Bakovic M (2006) Choline transport for phospholipid synthesis. Exp Biol Med 231:490–504
  34. Eliyahu G, Kreizman T, Degani H (2007) Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies. Int J Cancer 120:1721–1730
  35. Hara T, Bansal A, DeGrado TR (2006) Choline transporter as a novel target for molecular imaging of cancer. Mol Imaging 5:498–509
  36. Milosevic M, Fyles A, Hill R (1999) The relationship between elevated interstitial fluid pressure and blood flow in tumors: a bioengineering analysis. Int J Radiat Oncol Biol Phys 43:1111–1123
  37. Jain K (1987) Transport of molecules across tumor vasculature. Cancer Metastasis Rev 6:559–593